Abstract 1090: Type 2 endometrial cancer is associated with an M1 subtype, tumor associated macrophage polarization in the stromal compartment

Author(s):  
Michael G. Kelly ◽  
Antonio M.C. Francisco ◽  
Adela Cimic ◽  
Anne Wofford ◽  
Nora Fitzgerald ◽  
...  
2015 ◽  
Vol 22 (8) ◽  
pp. 948-953 ◽  
Author(s):  
Michael G. Kelly ◽  
Antonio M. C. Francisco ◽  
Adela Cimic ◽  
Anne Wofford ◽  
Nora C. Fitzgerald ◽  
...  

Autophagy ◽  
2020 ◽  
Vol 16 (11) ◽  
pp. 2069-2083 ◽  
Author(s):  
Enyong Dai ◽  
Leng Han ◽  
Jiao Liu ◽  
Yangchun Xie ◽  
Guido Kroemer ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Wei He ◽  
Ting Yuan ◽  
Kathrin Maedler

AbstractObesity is associated with inflammatory macrophages in insulin responsive tissues and the resulting inflammatory response is a major contributor to insulin resistance. In insulin-producing pancreatic islets, the intra-islet accumulation of macrophages is observed in patients of type 2 diabetes (T2D), but such has not been investigated in obese individuals. Here, we show that pro-inflammatory cytokines (IL-1β, IL-6, and TNF), anti-inflammatory cytokines (IL-10 and TGF-β) and macrophage polarization markers (CD11c, CD163, and NOS2) were expressed in isolated human islets from non-diabetic donors. Clodronate-mediated depletion of resident macrophages revealed expression of IL1B and IL10 mostly from macrophages, while IL6, TNF, and TGFB1 came largely from a non-macrophage origin in human islets. NOS2 expression came exclusively from non-macrophage cells in non-obese individuals, while it originated also from macrophages in obese donors. Macrophage marker expression of CD68, CD163, and ITGAX was unchanged in islets of non-obese control and obese cohorts. In contrast, IL1B and NOS2 were significantly increased in islets from obese, compared to non-obese individuals, implying a more inflammatory macrophage phenotype in islets in obesity. Our study shows elevated macrophage-associated inflammation in human islets in obesity, which could be an initiating factor to the pro-inflammatory intra-islet milieu and contribute to the higher susceptibility to T2D in obese individuals.


Diagnostics ◽  
2020 ◽  
Vol 10 (9) ◽  
pp. 635
Author(s):  
Aneta Cymbaluk-Płoska ◽  
Paula Gargulińska ◽  
Sebastian Kwiatkowski ◽  
Ewa Pius-Sadowska ◽  
Bogusław Machaliński

Galectin 3 is a modulator of several basic biological functions. It may be involved in the development of obesity and type 2 diabetes—risk factors of endometrial cancer. The study involved 144 patients, after abrasion due to postmenopausal bleeding. Galectin 3 concentrations were quantified in serum by multiplex fluorescent bead-based immunoassays. Median serum galectin 3 concentrations revealed significant differences between FIGO III and IV vs. FIGO I and II patients. Statistically higher concentrations were reported for patients with lymph node metastases compared to patients without it (p = 0.001) as well as in patients with lymphovascular space invasion compared to patients without LVSI (p = 0.02). No statistically significant differences were observed for median of galectin 3 levels depending on the surgical procedure (laparoscopy vs. laparotomy, p = 0.0608). Patients with galectin 3 levels exceeding the median value were characterized by overall survival being shorter by 11.9 months. High levels of galectin 3 were correlated with shorter disease-free survival, the difference is up to 14.8 months. Galectin 3 can be an independent prognostic factor in patients with endometrial cancer. Among the recognized prognostic factors and the concentrations of the galectin 3 marker at the adopted time points, the univariate analysis showed a significant effect of staging, grading, and cutoff galectin 3 on the OS. For multivariate analysis, the galectin 3 cutoff point had the greatest significant impact on OS.


Sign in / Sign up

Export Citation Format

Share Document